The latest announcement is out from Recursion Pharmaceuticals ( ($RXRX) ). On November 26, 2025, Recursion Pharmaceuticals filed a prospectus ...
Recursion Pharmaceuticals Inc's (NYSE: RXRX) short interest as a percent of float has fallen 15.85% since its last report.
Few would place Recursion Pharmaceuticals (NASDAQ: RXRX), a little-known biotech company, in the same league as these tech ...
Unrestricted large language models (LLMs) like WormGPT 4 and KawaiiGPT are improving their capabilities to generate malicious ...
When attempting to create the pgmq extension on Supabase Postgres images version 17.6.1.016 and later, the installation fails with a PostgreSQL error 42725: function ...
The Food and Drug Administration (FDA) faces criticism for restricting access to 7-hydroxymitragynine (7-OH), a kratom-derived compound that offers relief from chronic pain and opioid withdrawal. The ...
After a strong rally in the S&P 500 in August, the US stock market entered September, a typically weak month, with a slight correction. Over the past decade, September has been the worst-performing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback